Logo image of SEQUA.BR

SEQUANA MEDICAL NV (SEQUA.BR) Stock Price, Quote, News and Overview

EBR:SEQUA - Euronext Brussels - BE0974340722 - Common Stock - Currency: EUR

1.03  0 (0%)

SEQUA.BR Quote, Performance and Key Statistics

SEQUANA MEDICAL NV

EBR:SEQUA (4/25/2025, 7:00:00 PM)

1.03

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High4.39
52 Week Low0.47
Market Cap54.46M
Shares52.87M
Float44.42M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-11 2019-02-11


SEQUA.BR short term performance overview.The bars show the price performance of SEQUA.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40 -60

SEQUA.BR long term performance overview.The bars show the price performance of SEQUA.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SEQUA.BR is 1.03 EUR. In the past month the price increased by 3%. In the past year, price decreased by -25.9%.

SEQUANA MEDICAL NV / SEQUA Daily stock chart

SEQUA.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 26.78 195.04B
IUI1.DE INTUITIVE SURGICAL INC 69.6 160.59B
1ISRG.MI INTUITIVE SURGICAL INC 67.37 155.44B
BSX.DE BOSTON SCIENTIFIC CORP 40.27 131.64B
2M6.DE MEDTRONIC PLC 15.7 94.46B
SHL.DE SIEMENS HEALTHINEERS AG 20.82 52.84B
BOX.DE BECTON DICKINSON AND CO 14.61 51.31B
EWL.DE EDWARDS LIFESCIENCES CORP 28.95 39.15B
DC4.DE DEXCOM INC 43.32 24.63B
PHI1.DE KONINKLIJKE PHILIPS NV 15.88 20.74B
PHIA.AS KONINKLIJKE PHILIPS NV 15.87 20.74B
BIM.PA BIOMERIEUX 29.92 13.67B

About SEQUA.BR

Company Profile

SEQUA logo image Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 62 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

Company Info

SEQUANA MEDICAL NV

Kortrijksesteenweg 1112, Sint-Denijs-Westrem

Ghent OOST-VLAANDEREN BE

Employees: 62

Company Website: https://www.sequanamedical.com/

Investor Relations: http://www.sequanamedical.com/investors/

Phone: 3292928065.0

SEQUANA MEDICAL NV / SEQUA.BR FAQ

What is the stock price of SEQUANA MEDICAL NV today?

The current stock price of SEQUA.BR is 1.03 EUR.


What is the ticker symbol for SEQUANA MEDICAL NV stock?

The exchange symbol of SEQUANA MEDICAL NV is SEQUA and it is listed on the Euronext Brussels exchange.


On which exchange is SEQUA.BR stock listed?

SEQUA.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for SEQUANA MEDICAL NV stock?

11 analysts have analysed SEQUA.BR and the average price target is 4.05 EUR. This implies a price increase of 292.82% is expected in the next year compared to the current price of 1.03. Check the SEQUANA MEDICAL NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SEQUANA MEDICAL NV worth?

SEQUANA MEDICAL NV (SEQUA.BR) has a market capitalization of 54.46M EUR. This makes SEQUA.BR a Micro Cap stock.


How many employees does SEQUANA MEDICAL NV have?

SEQUANA MEDICAL NV (SEQUA.BR) currently has 62 employees.


What are the support and resistance levels for SEQUANA MEDICAL NV (SEQUA.BR) stock?

SEQUANA MEDICAL NV (SEQUA.BR) has a support level at 1.02 and a resistance level at 1.05. Check the full technical report for a detailed analysis of SEQUA.BR support and resistance levels.


Is SEQUANA MEDICAL NV (SEQUA.BR) expected to grow?

The Revenue of SEQUANA MEDICAL NV (SEQUA.BR) is expected to grow by 10652% in the next year. Check the estimates tab for more information on the SEQUA.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SEQUANA MEDICAL NV (SEQUA.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SEQUANA MEDICAL NV (SEQUA.BR) stock pay dividends?

SEQUA.BR does not pay a dividend.


What is the Price/Earnings (PE) ratio of SEQUANA MEDICAL NV (SEQUA.BR)?

SEQUANA MEDICAL NV (SEQUA.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.05).


SEQUA.BR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SEQUA.BR. When comparing the yearly performance of all stocks, SEQUA.BR is a bad performer in the overall market: 96.38% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SEQUA.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR. Both the profitability and financial health of SEQUA.BR have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SEQUA.BR Financial Highlights

Over the last trailing twelve months SEQUA.BR reported a non-GAAP Earnings per Share(EPS) of -1.05. The EPS increased by 13.49% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -251.92%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-17.48%
Sales Q2Q%-100%
EPS 1Y (TTM)13.49%
Revenue 1Y (TTM)-85.19%

SEQUA.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to SEQUA.BR. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 47.62% and a revenue growth 10652% for SEQUA.BR


Ownership
Inst Owners49.55%
Ins Owners3.45%
Short Float %N/A
Short RatioN/A
Analysts
Analysts83.64
Price Target4.05 (293.2%)
EPS Next Y47.62%
Revenue Next Year10652%